Otsuka (OTCMKTS:OTSKY) Shares Gap Down – What’s Next?

by · The Markets Daily

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY – Get Free Report) shares gapped down prior to trading on Friday . The stock had previously closed at $39.39, but opened at $38.23. Otsuka shares last traded at $38.4950, with a volume of 815 shares traded.

Otsuka Stock Performance

The company has a debt-to-equity ratio of 0.05, a current ratio of 2.17 and a quick ratio of 1.67. The business has a 50-day simple moving average of $35.30 and a 200-day simple moving average of $34.47. The firm has a market capitalization of $41.30 billion, a PE ratio of 15.44, a P/E/G ratio of 2.76 and a beta of -0.04.

Otsuka (OTCMKTS:OTSKY – Get Free Report) last posted its quarterly earnings data on Friday, July 31st. The company reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.19. The business had revenue of $4.41 billion during the quarter, compared to analyst estimates of $3.95 billion. Otsuka had a return on equity of 12.93% and a net margin of 15.50%.Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. Equities research analysts expect that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 earnings per share for the current fiscal year.

About Otsuka

(Get Free Report)

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.

See Also